Kidney Treatment

---

PP02 | Cryoablation therapy with lipiodol marking for small renal masses
F. Hongo¹, Y. Naya¹, Y. Yamada¹, T. Ueda¹, T. Shiraishi¹, H. Nakanishi¹, T. Nakamura¹, K. Kamoi¹, K. Okihara¹, Y. Ichijyo², K. Yamada², T. Miki¹
1 Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan
2 Department of Radiology, Kyoto Prefectural University of Medicine, Kyoto, Japan

                     PP03 | WITHDRAWN

PP04 | Comparison of under open-MRI and CT scan in treatment outcome of percutaneous renal cryoablation for small renal tumors
K. Miki, S. Egawa
Jikei University School of Medicine, Tokyo, Japan

PP05 | Percutaneous 3T MR-guided cryoablation of small renal masses: initial experience
T.J. van Oostenbrugge^1,2, J.F. Langenhuijsen², S.F.M. Jenniskens¹, P.F.A. Mulders², J.J. Fütterer^1,3
1 Department of Radiology, Radboud University Medical Center, Nijmegen, the Netherlands
2 Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands
3 MIRA, Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands

Prostate Imaging

---

                     PP06 | WITHDRAWN

PP07 | Routine use of magnetic resonance imaging in prostate cancer facilitates better candidate selection for active surveillance
A. Sivaraman, R. Sanchez-Salas, A. Youness, E. Barret, M. Galinao, F. Rozet, D. Prapotnich, N. Cathala, A. Mombet, X. Cathelineau
Institut Mutualiste Montsouris, Paris, France

PP08 | Transperineal MRI visually-targeted prostate biopsies compared to template mapping biopsy in 400 men requiring further risk stratification
A.D.R. Grey, T.R. Hartington, C. Allen, M. Arya, M. Emberton, A. Freeman, C. Jameson, A.P. Kirkham, C.M. Moore, S. Punwani, N. Ramachandran, G. Trevisan, M. Walkden, H.U. Ahmed
UCLH, London, United Kingdom

PP09 | Eligibility analysis for focal therapy based on prostatectomy findings: does intermediate-risk cancer have a higher likelihood of undertreatment than low-risk cancer?
Y. Matsuoka¹, N. Numao¹, K. Saito¹, H. Tanaka², M. Ito¹, S. Yoshida¹, M. Yokoyama¹, J. Ishioka¹, Y. Fujii¹, K. Kihara¹
1 Tokyo Medical and Dental University Graduate School, Tokyo, Japan
2 Ochanomizu Surugadai Clinic, Tokyo, Japan

PP10 | DCE-MRI dispersion imaging in prostate cancer
S. Turco, C. Lavini, J.J de la Rosette, H. Wijkstra, M. Mischi
Eindhoven University of Technology, Eindhoven, the Netherlands

PP11 | 3D contrast-ultrasound dispersion imaging for prostate cancer localization: a feasibility study
M. Mischi¹, S. Schalk¹, M. Smeenge², L. Demi¹, J.J de la Rosette², H. Wijkstra²
1 Eindhoven University of Technology, Eindhoven, the Netherlands
2 Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

PP12 | MRI-guided biopsy of visible tumors to guide focal therapy
A. McPartlin, P. Chung, A. Simeonov, T. van der Kwast, S. Ghai, C. Catton, R. Bristow, A. Bayley, P. Warde, M. Gospodarowicz, C. Ménard
Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

PP13 | Feasibility of 3D TRUS reconstruction by two perpendicular 2D sweep videos
S. Schalk¹, C. Chen^1,2, L. Demi¹, A. Postema², J. de la Rosette², H. Wijkstra^1,2, M. Mischi¹
1 Eindhoven University of Technology, Eindhoven, the Netherlands
2 AMC Academic Hospital, Amsterdam, the Netherlands

PP14 | Efficient sampling methods in systematic biopsy that could be performed in combination with MRI-guided biopsy
N. Numao, M. Ito, S. Yoshida, M. Yokoyama, J. Ishioka, Y. Matsuoka, K. Saito, Y. Fujii, K. Kihara
Tokyo Medical and Dental University Graduate School, Tokyo, Japan

PP15 | The value of the MR/ultrasound fusion in primary prostate biopsy
F. Distler, J.P. Radtke, C. Kesch, M. Roethke, H.-P. Schlemmer, W. Roth, M. Hohenfellner, B. Hadaschik
University of Heidelberg, Heidelberg, Germany

PP16 | Prostate cancer volume estimation by combining magnetic resonance imaging and targeted biopsy-proven cancer core-length: correlation with cancer volume
T. Matsugasumi, E. Baco, Y. Sato, N. Fukuda, I. Gill, O. Ukimura
Department of Urology, University of Southern California, Los Angeles, CA, USA

PP17 | Three-dimensionally documented biopsy mapping allows precise re-visiting of prostate cancer foci with serial surveillance of cell cycle progression gene panel
O. Ukimura, T. Matsugasumi, S. Ushijima, M. Kanazawa, A.L.C. Abreu, I. Gill
Department of Urology, University of Southern California, Los Angeles, CA, USA

PP18 | Evolution of prostate cancer detection by mpMRI-based screening: how we could reduce the number of unnecessary biopsies
K. Kamoi, K. Okihara, F. Hongo, Y. Naya, N. Yasuyuki, I. Atsuko, T. Nakamura, T. Miki
Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan

PP19 | Confronting the challenge of “virtual” prostate biopsy
C. Otte¹, A. Patel², A. Schlaefer¹, S. Otte³, T. Loke², T. Ngo², D. Nir⁴, M. Winkler²
1 Hamburg University of Technology, Hamburg, Germany
2 Imperial College NHS Trust, London, United Kingdom
3 Private practice, Hamburg, Germany
4 Radbee, Oxford, United Kingdom

PP20 | MRI and CEUS imaging for evaluation of IRE treatment: results from a phase I/II study in prostate cancer patients undergoing IRE followed by radical prostatectomy
W. van den Bos¹, D.M. de Bruin^1,2, A. van Randen³, M.R.W. Engelbrecht³, A.W. Postema¹, B.G. Muller¹, I.M. Varkarakis⁴, A. Skolarikos⁴, C.D. Savci-Heijink⁵, R.R. Jurhill⁵, P.J. Zondervan¹, M.P. Laguna¹, H. Wijkstra^1,6, T.M. de Reijke¹, J.J.M.C.H. de la Rosette¹
1 Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
2 Department of Biomedical Engineering and Physics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
3 Department of Radiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
4 2nd Department of Urology, University of Athens, Sismanoglio General Hospital, Athens, Greece
5 Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
6 Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands

PP21 | A novel optical biopsy probe design combining elastic scattering spectroscopy and optical coherence tomography
A. Swaan^1,2, P.R. Bloemen¹, D.M. De Bruin^1,2, H.J.C.M Sterenborg¹, D.J. Faber¹, J.J. De la Rosette², T.G. van Leeuwen¹
1 Department of Biomedical Engineering and Physics, University of Amsterdam, Amsterdam, the Netherlands
2 Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands

PP22 | Prostate cancer diagnosis: towards diagnostic accuracy of needle-based optical coherence tomography
B.G. Muller¹, D.M. de Bruin¹, M.J. Brandt¹, W. van den Bos¹, S. van Huystee², D.J. Faber¹, D. Savci¹, P.J. Zondervan¹, T.M. de Reijke¹, M.P. Laguna Pes¹, T.G. van Leeuwen¹, J.J. de la Rosette¹
1 AMC, Amsterdam, the Netherlands
2 VUMC, Amsterdam, the Netherlands

PP23 | A randomized controlled trial to assess and compare the outcomes of 2-core MRI/TRUS-image-fusion guided prostate biopsy and traditional 12-core systematic biopsy
E. Baco
Oslo University Hospital, Oslo, Norway

PP24 | Single-centre experience with systematic transperineal stereotactic prostate biopsy plus magnetic resonance imaging targeted, transrectal ultrasound guided fusion biopsy
M. Musch¹, A.B. Malik², J. Schwerfeld-Bohr¹, U. Roggenbuck³, J.L. Hohenhorst¹, B. Taskiran¹, R. Herholz¹, T. Ebel⁴, J.-A. Koch², D. Kroepfl¹
1 Department for Urology, Pediatric Urology and Urological Oncology, Kliniken Essen-Mitte, Essen, Germany
2 Department for Diagnostic and Interventional Radiology, Kliniken Essen-Mitte, Essen, Germany
3 Institute for Medical Informatics, Biometry and Epidemiology, University of Duisburg-Essen, Essen, Germany
4 Institute for Pathology Essen-Mitte, Essen, Germany
    
PP25 | Use of novel software-based compensation of local prostate deformation resulting from focal therapy to accurately define a target for post-therapy follow-up
C. Orczyk^1-2, A.B. Rosenkrantz², H. Rusinek², A. Mikheev², J. Le Nobin³, S. Valable³, A. Villers³, S.S Taneja²
1 University College London, London, United Kingdom
2 New York University Medical Center, New York, NY, USA
3 CHRU Lille, Lille, France

PP26 | Accuracy of three-dimensional prostate cancer map based on MR/US fusion biopsy
K. Kamoi, K. Okihara, F. Hongo, Y. Naya, N. Yasuyuki, I. Atsuko, T. Nakamura, T. Miki
Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan

PP26b | Multiparametric magnetic resonance imaging for detection and localization of prostate cancer: diagnostic properties  
K.J. Tay¹, M. Mendez¹, M. Tsivian¹, R. Gupta², P. Qi¹, M. Abern¹, N. Passoni¹, T. Polascik¹
1 Division of Urology, Duke Cancer Institute, Durham, NC, USA
2 Department of Radiology, Duke University Medical Center, Durham, NC, USA

Prostate Treatment

---

PP27 | Focal One^® – More than simple HIFU
M. Schostak¹, D. Eberli², D. Baumunk¹, R. Ganzer³, N. Harke⁴, T. Kuru⁵, J. von Hardenberg⁶, J. Wendler¹, D. Koch⁷, T. Sulser², J. Witt⁴, M.-S. Michel⁶, J.-U. Stolzenburg³, A. Heidenreich⁵, A. Blana⁷
1 University of Magdeburg, Magdeburg, Germany
2 University of Zurich, Zurich, Switzerland
3 University of Leipzig, Leipzig, Germany
4 St. Antonius Hospital, Gronau, Germany
5 University of Aachen, Aachen, Germany
6 University of Mannheim, Mannheim, Germany
7 Klinikum Fuerth, Fuerth, Germany

PP28 | PSA screening – The impact prostate cancer detection and the implications for management and delivery of service
A. Dyal, S. Rai, S. Ubee, P.H. Rajjayabun
Worcestershire Acute NHS Trust, Redditch, United Kingdom

PP29 | Comparision of perioperative and oncologic outcomes of focal cryotherapy in unilateral, organ confined prostate cancer (PCa) with Gleason score 6(3+3) vs. 7(3+4)
A. Sivaraman, F. Uriburu Pizarro, E. Barret, R. Sanchez-Salas, M. Galinao, F. Rozet, D. Prapotnich, N. Cathala, A. Mombet, X. Cathelineau
Institut Mutualiste Montsouris, Paris, France

PP30 | Focal high intensity focused ultrasound targeted hemiablation for unilateral prostate cancer – A prospective evaluation of oncologic and functional outcomes
A. Sivaraman, E.R. Cordeiro Feijoo, E. Barret, R. Sanchez-Salas, M. Galinao, F. Rozet, D. Prapotnich, N. Cathala, A. Mombet, X. Cathelineau
Institut Mutualiste Montsouris, Paris, France

PP31 | Morphological analysis of the effects of intra-operative transrectal compression of the prostate during high intensity focused ultrasound for localized prostate cancer: implication for lesion targeted focal therapy
S. Shoji¹, T. Higure¹, M. Kawakami¹, M. Nakano¹, T. Terachi², T. Uchida¹
1 Tokai University, Hachioji Hospital, Hachioji, Japan
2 School of Medicine, Tokai University, Isehara, Japan

PP32 | Real time magnetic resonance guided focused ultrasound for focal therapy of locally confined low-intermediate risk prostate cancer: feasibility and preliminary outcomes
S. Ghai, A. Louis, M. Van Vliet, U. Lindner, M. Haider, E. Hlasny, P. Spensieri, T. van der Kwast, S. McCluskey, W. Kucharczyk, J. Trachtenberg
University Health Network, University of Toronto, Toronto, ON, Canada

PP33 | Focal therapy for prostate cancer with hemi-gland low dose rate brachytherapy
K. Saito, Y. Matsuoka, N. Numao, K. Hayashi, S. Yoshida, M. Yokoyama, J. Ishioka, Y. Fujii, R. Yoshimura, K. Kihara
Tokyo Medical and Dental University Graduate School, Tokyo, Japan

PP34 | Focal therapy with HIFU for prostate cancer: our experience
A.V. Amosov, I.S. Lumpov, G.E. Krupinov, T.M. Ganzha
I.M. Sechenov First Moscow State Medical University, Moscow, Russia

PP35 | Nintedanib effects on steroid hormones and growth factors in prostate cancer from TRAMP mice
R.F. Silva, E.N. Lima, L.A. Kido, F. Montico, T.P. Banzato, J.E. Carvalho, V.E.A. Cagnon
UNICAMP, Campinas, Brazil

PP36 | Focal salvage MRI-guided cryotherapy for radiation recurrent prostate cancer: predictors of patient outcome
C. Overduin, S. Jenniskens, M. Sedelaar, J. Bomers, J. Fütterer
Radboud University Medical Centre, Nijmegen, the Netherlands

PP37 | Focal salvage MRI-guided cryoablation for localized prostate cancer recurrence after radiotherapy; 1 year follow-up
J.G.R. Bomers, S.F.M. Jenniskens, E.B. Cornel, C.G. Overduin, E.N.J.T. van Lin, J.P.M. Sedelaar, J.J. Fütterer
Radboud University Medical Centre, Nijmegen, the Netherlands

PP38 | Autologous fat transfer as a prostate-rectum spacer: feasibility, technique and early results
M. Borghi, M. Bou, E.F. Becher, P.H. Rios, V. Chernobilsky, L. Monts de Oca
CDU, Buenos Aires, Argentina

PP39 | Focal cryotherapy in the treatment of localized prostate cancer: early outcomes
T.T. Shah¹, B. Thomas¹, M. Valerio¹, M.Ghei², H.U. Ahmed¹, M. Arya³
1 UCL, London, United Kingdom
2 Whittington Hospital NHS Trust, London, United Kingdom
3 UCLH, London, United Kingdom

PP40 | Semi-automated prostate biopsy core download system – Performance and implications
M. Cohen¹, B. Yudkevich¹, A. Pasternak², K. Shapira-Schweitzer², H. Yodko³, I. Elmalah³
1 Department of Urology, Emek Medical Center, Afula, Israel
2 UC-CARE Medical Center Systems, Yokneam, Israel
3 Department of Pathology, Emek Medical Center, Afula, Israel

PP41 | Different opinions toward salvage prostate brachytherapy: an Uro-GEC Delphi study
M. Kaljouw
AMC, Amsterdam, The Netherlands

PP42 | Prospective trial of regional (hockey-stick) prostate cryoablation: 5-year pathologic and quality of life outcomes
J. Ward, H. Choi, M. Lozano, S. McRae, A. Venkatesan, J. Davis, M. Munsell, G.M. Nogueras-Gonzalez, M.F. Achim, M. Satyajit Sampatrao, L. Pisters
M.D. Anderson Cancer Center, Houston, TX, USA

PP43 | “Prostate Cartography”: Targeted and systematic perineal stereotactic prostate biopsy using the BiopSee^® platform in locating prostate cancer foci and facilitating focal treatment
J. Schwerfeld-Bohr¹, J.L. Hohenhorst¹, M. Musch¹, A. Pailliart¹, M. Vanberg¹, S. Krege¹, D. Kröpfl¹, G. Sakas²
1 Department for Urology, Pediatric Urology and Urological Oncology, Kliniken Essen-Mitte, Essen, Germany
2 Medcom GmbH, Darmstadt, Germany

PP44 | Investigation of target region for focal therapy of prostate cancer: analysis of 104 radical prostatectomy specimens
K. Kanao, K. Kajikawa, M. Sumitomo
Aichi Medical University, Nagakute, Japan

PP45 | Focal HIFU (Focal One^®) treatment of localized prostate cancer diagnosed and controlled with MRI-ultrasound fusion targeted biopsies (Koelis®): preliminary results
P. Nevoux¹, J. Lacoste¹, T. Rousseau¹, G. Le Coguic¹, G. Aillet², E. Potiron¹
1 Clinique Urologique Nantes Atlantis, Nantes, France
2 Institut d'Histopathologie, Nantes, France

PP46 | Feasibility, safety, and efficacy of salvage radical prostatectomy after focal treatment for localized prostate cancer: 5 first cases in a single center
P. Nevoux¹, J. Lacoste¹, T. Rousseau¹, G. Le Coguic¹, G. Aillet², E. Potiron¹
1 Clinique Urologique Nantes Atlantis, Nantes, France
2 Institut d'Histopathologie, Nantes, France

PP47 | HIFU hemi ablation treatment for local recurrence post EBRT prostate cancer. Oncologic results
H. Rios Pita, M. Borghi, E.F. Becher, L. Montes De Oca
CDU, Buenos Aires, Argentina

PP48 | The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients
W. van den Bos¹, D.M. de Bruin^1,3, R.R. Jurhill², C.D. Savci Heijink², B.G. Muller¹, I.M. Varkarakis⁴, A. Skolarikos⁴, P.J. Zondervan¹, M.P. Laguna-Pes¹, H. Wijkstra^1,5, T.M. de Reijke¹, J.J.M.C.H. de la Rosette¹
1 Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
2 Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
3 Department of Biomedical Engineering and Physics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
4 2nd Department of Urology, Athens Medical University, University of Athens, Athens, Greece
5 Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands

PP49 | Quality of life and safety outcomes following irreversible electroporation treatment for prostate cancer
W. van den Bos¹, D.M. de Bruin^1,2, D.P. Veelo³, A.W. Postema¹, B.G. Muller¹, I.M. Varkarakis⁴, A.A. Karagiannis⁴, P.J. Zondervan¹, M.P. Laguna Pes¹, H. Wijkstra^1,5, T.M. de Reijke¹, J.J.M.C.H. de la Rosette¹
1 Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
2 Department of Biomedical Engineering and Physics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
3 Department of Anaesthesiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
4 2nd Department of Urology, University of Athens, Sismanoglio General Hospital, Athens, Greece
5 Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
6 Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands

PP50 | MRI-guided transurethral ultrasound ablation in patients with localized prostate cancer: 12-month outcomes of a prospective multicentric phase I clinical trial
I.V. Popeneciu¹, M. Billia², J. Hafron³, M. Burtnyk⁴, T.H. Kuru¹, G. Hatiboglu¹, M. Roethke⁵, H.-P. Schlemmer⁵, J. Relle³, M. Hohenfellner¹, J. Chin², S. Pahernik¹
1 Department of Urology, University Hospital, Heidelberg, Germany
2 Department of Urology, Western University UWO, London Health Sciences Center, London Victoria Hospital, London, ON, Canada
3 Department of Urology, Beaumont Health System, Royal Oak, MI, USA
4 Profound Medical Inc., Toronto, ON, Canada
5 Department of Radiology, German Cancer Research Center DKFZ, Heidelberg, Germany

PP51 | MRI guided focal HDR brachytherapy for localized prostate cancer
M. Maenhout, V. van der Voort, J. van Zyp, M. Moerland, M. van Vulpen
UMC Utrecht, Utrecht, the Netherlands

PP52 | Smartphone cancer app usage among EAU Delegates – A survey
N. Pereira-Azevedo, I. Braga, J. Cabral, V. Cavadas, L. Osorio, A. Fraga
Porto Hospital Centre, Porto, Portugal

PP53 | High-resolution glycosylation profiling of prostate-specific antigen for evaluating its diagnostic potential of prostate cancer
G.S.M. Kammeijer¹, N. de Haan¹, J.J.M.C.H. de la Rosette², M. Wuhrer^1,3, T.M. de Reijke²
1 Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, the Netherlands
2 Department of Urology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
3 Division of BioAnalytical Chemistry, VU University Amsterdam, Amsterdam, the Netherlands

PP54 | Focal cryotherapy delivers similar oncological control with significantly improved erectile function recovery rates over a whole gland approach
K.J. Tay¹, M. Mendez¹, T. Polascik¹, N. Passoni¹, J. Pow-Sang², A. El-Shafei³, J.S. Jones³
1 Duke University Medical Center, Durham, NC, USA
2 Mofitt Cancer Center, Tampa, FL, USA
3 Cleveland Clinic, Cleveland, OH, USA

PP55 | Early outcomes of combination MRI-targeted and saturation trans-perineal biopsy in restaging low-risk prostate cancer for active surveillance
K.J. Tay¹, K. Chen¹, Y.M. Law², H. Ho¹, J. Yuen¹, C. Cheng¹
1 Department of Urology, Singapore General Hospital, Singapore
2 Department of Radiology, Singapore General Hospital, Singapore